Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Liquid Handling System

By Drug Discovery Trends Editor | November 1, 2012

Agilent Technologies Inc. announced the Encore Multispan liquid handling system, featuring an array of unique technological advances in a single instrument. The Encore Multispan liquid handling system will enable new automation capabilities that improve every stage of the research process.

The Encore Multispan system combines innovative multispan pipetting with the reach of a built-in robotic arm and intelligent software control to deliver a new level of productivity and throughput.  Using the Encore Multispan system, researchers will be able to easily automate a larger portion of their workflow and significantly expand their walkaway time.

The Encore Multispan system combines advanced liquid handling and robotics to enable true sample-to-analysis automation. Agilent’s experience in workflow automation and liquid handling has allowed for the integration of both technologies into a single platform.

The Encore Multispan liquid handling system will include the following innovations:

• A dual, multispan pipetting system provides two individual banks of multiple pipettes where each moves independently in multiple axes, delivering ultimate speed and double the throughput available today.  Each pipette can address a variety of sample formats, from tubes to vials to microplates.
• An innovative and powerful software package features a 3-D simulator that provides researchers with the ability to set up, visualize, and optimize their protocols remotely and offline prior to running valuable experiments on the system.
• A built-in robotic arm provides a span of up to 21 inches off-deck with patented one-touch easy teaching that enables end-to-end workflow integrations with unprecedented range and flexibility.

The combination of these unique capabilities will provide researchers with the ability to quickly and easily automate complete workflows for a wide range of applications, including high-throughput screening, ELISA, ADME/TOX, compound management and sample-preparation workflows for genomics, proteomics, and more.

Agilent Technologies Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE